A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma
Clinical trial NCT04385550 · UNKNOWN
Trial details
- NCT number
- NCT04385550
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-20
- Primary completion
- 2023-10-31
- Enrollment
- 528
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.